Emergency Contraception With the Progestin IUD

This transcript has been edited for clarity.

Hello. I'm Andrew Kaunitz, professor and associate chair in the ob/gyn department at the University of Florida College of Medicine in Jacksonville. Today I'd like to discuss the use of progestin intrauterine devices (IUDs) for emergency contraception. 

Due to their convenience and high efficacy, a growing number of US women are using intrauterine contraception. More women are choosing progestin-releasing IUDs over the copper IUD. Although the copper IUD is known to provide highly effective emergency contraception, little data address use of progestin-releasing IUDs for this indication.

In an NIH-funded clinical trial, investigators based in family planning clinics in Utah randomly assigned women who presented for emergency contraception following one or more episodes of unprotected sex in the prior 5 days to a levonorgestrel or a copper IUD.

At baseline, all participants had a negative urine pregnancy test. The progestin IUDs used in this trial contained 52 mg of levonorgestrel. Brand names for such IUDs are Liletta or Mirena. The primary outcome was having a positive urine pregnancy test 1 month after IUD placement.

One-month outcome data were available for almost 650 participants. One pregnancy occurred in the levonorgestrel IUD group, resulting in a pregnancy rate of 0.3% or 3 per 1000. No pregnancies occurred in the copper IUD group. The single pregnancy resulted in a